Day One Biopharmaceuticals I
+$1.1B
Net Activity
Institutions Holding
209
Popularity Rank
#2779
Avg Weight
0.25%
Total Value
$1.9B
Ownership Trend
209 institutions currently hold DAWNGBX, with 138 net buyers and 106 net sellers this quarter.
Institutional Moves
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
106
Net Buying Institutions
138
Key Holders
Key Holders
Top 5 by Value
Quarterly Activity
Recent Activity
+$1.3B
Total Buy Value
$558.4M
Total Sell Value
138
Net Buyers
106
Net Sellers
Insider Trading (Form 4)
Form 144 Pre-Sale Notices
No Form 144 planned sale filings in the last 90 days
Beneficial Ownership (13D/13G)
No Schedule 13D/13G filings for this ticker
Material Events (8-K)
No Form 8-K filings for this ticker
FAQ
Who are the top institutional investors holding DAY ONE BIOPHARMACEUTICALS I (DAWNGBX)?
What is the overall institutional sentiment toward DAWNGBX recently?
Which institutions have been selling or reducing their DAWNGBX positions?
Are there any notable investors adding DAWNGBX to their portfolios?
Related Stocks
Trending Institutional Adds
The most-added stocks by 13F institutions this quarter
Microsoft CORP
Institutions Holding
601
Total reported value
$20.1B
310 13F institutions increased their position this quarter
Nvidia CORP
Institutions Holding
563
Total reported value
$25.2B
299 13F institutions increased their position this quarter
Vanguard Growth ETF
Institutions Holding
302
Total reported value
$4.3B
269 13F institutions increased their position this quarter